South Africa: ARV vaginal ring next prevention hope

Researchers have started testing the safety a vaginal ring containing an antiretroviral drug in South Africa in the hope that it has the potential to prevent HIV infection in women. The clinical trial, known as IPM 015 will test the safety and acceptability of the dapivirine-containing vaginal ring – which is successfully used in Europe as a delivery method for hormonal therapy and birth control.